New Treatment for Obsessive-Compulsive Disorder with Dr. Nolan Williams

Dr. Nolan Williams, Clinical Assistant Professor of Psychiatry and Behavioral Sciences at Stanford University. We speak about new treatment options for use in treatment-resistant patients with OCD, including brain stimulation. A deep TMS device was recently FDA approved for the treatment of treatment-resistant OCD.Deep brain stimulation works to target specific areas of the brain and can affect the treatment of certain disorders including OCD and depression. Brain stimulation devices utilizing transcranial magnetic stimulation (TMS) technology have also recently been approved to treat disorders including OCD and depression. About OCD: Over 1.2 million OCD patients are considered treatment resistant to first-line therapies, including SSRIs. After first-line therapies fail, many physicians consider neuromodulation options such as brain surgery. A new, non-invasive neuromodulation strategy involves TMS targeting the anterior cingulate cortex region of the brain. In addition to providing another treatment option for patients and improving patient quality of life, TMS may also be more cost effective for patients.Become a supporter of this podcast: https://www.spreaker.com/podcast/mental-health-news-radio--3082057/support.